Src family kinase oncogenic potential and pathways in prostate cancer as revealed by AZD0530

Cancer Statistics, 2008

Ahmedin Jemal, Rebecca L. Siegel, Elizabeth Ward et al. · CA A Cancer Journal for Clinicians · 2008 · 10.2K citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase B

Darren A.E. Cross, Dario R. Alessi, Philip Cohen et al. · Nature · 1995 · 5.2K citations

Life Sciences, Biochemistry, Molecular Biology +12

Glycogen synthase kinase-3β regulates cyclin D1 proteolysis and subcellular localization

J. Alan Diehl, Mangeng Cheng, Martine F. Roussel et al. · Genes & Development · 1998 · 2.1K citations · Full text

Life Sciences, Biochemistry, Cell Biology +17

Discovery of <i>N</i>-(2-Chloro-6-methyl- phenyl)-2-(6-(4-(2-hydroxyethyl)- piperazin-1-yl)-2-methylpyrimidin-4- ylamino)thiazole-5-carboxamide (BMS-354825), a Dual Src/Abl Kinase Inhibitor with Potent Antitumor Activity in Preclinical Assays

Louis J. Lombardo, Francis Y. Lee, Ping Chen et al. · Journal of Medicinal Chemistry · 2004 · 1.3K citations · Full text

Medicine, Oncology, Pharmacology +13

Overexpression of mouse D-type cyclins accelerates G1 phase in rodent fibroblasts.

Dawn E. Quelle, Richard A. Ashmun, Sheila Shurtleff et al. · Genes & Development · 1993 · 1K citations · Full text

Life Sciences, Cell Biology, Molecular Biology +14